Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 48: 354-356, 2002;
This Article
Right arrow Extract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (9)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lai, C.-C.
Right arrow Articles by Lee, C.-C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lai, C.-C.
Right arrow Articles by Lee, C.-C.
Related Collections
Right arrow Molecular Diagnostics and Genetics
Right arrow Endocrinology and Metabolism
(Clinical Chemistry. 2002;48:354-356.)
© 2002 American Association for Clinical Chemistry, Inc.


Technical Briefs

Monitoring of Congenital Adrenal Hyperplasia by Microbore HPLC–Electrospray Ionization Tandem Mass Spectrometry of Dried Blood Spots

Chien-Chen Lai1, Chang-Hai Tsai1, Fuu-Jen Tsai1a, Jer-Yuarn Wu1, Wei-De Lin1 and Cheng-Chun Lee1

1 Department of Medical Genetics and Medical Research, China Medical College Hospital, Taichung, 404 Taiwan

aaddress correspondence to this author at: Department of Pediatrics, Medical Genetics and Medical Research, China Medical College Hospital, No. 2, Yuh-Der Road, Taichung, 404 Taiwan; fax 886-4-22033295, e-mail d0704{at}www.cmch.org.tw

Congenital adrenal hyperplasia (CAH), a disorder caused by a deficiency of the 21-hydroxylase enzyme, is the most common inborn error of the adrenal steroid pathways. Early diagnosis of CAH can be lifesaving, and screening for CAH in newborns by measuring 17{alpha}-hydroxyprogesterone (17OHP) or other steroids has become a routine part of many programs (1)(2). These steroid hormones have been measured by fluorometry (3)(4), immunoassay (5)(6)(7)(8), and HPLC (4)(9)(10). Most methods are affected by interferences or cross-reactivity with other steroids. Currently, neonatal screening and monitoring for CAH use immunoassays (3)(4). This approach, although practical, lacks specificity because cross-reacting congeners are inseparable from 17OHP in the direct assay (4)(11)(12)(13).

Electrospray ionization (ESI) has become an important method for the generation of gas-phase ions from biomolecules for mass spectrometric analysis, but the low proton affinity of natural steroids compromises their measurement by ESI. To improve sensitivity, we have derivatized steroids to form a covalent bond containing a permanent positively charged nitrogen atom. The carbonyl compound 17OHP was derivatized with a quaternary ammonium salt, Girard reagent P (GirP), to form water-soluble hydrazones with a permanently charged pyridine moiety. This derivative was selected for its introduction of a positive charge into the molecule of ketosteroid 17OHP and for the ease of its synthesis (14).

The purpose of this study was to evaluate the applicability of liquid chromatography-tandem mass spectrometry (LC-MS/MS) to clinical analysis of 17OHP in dried filter-paper blood samples from patients with CAH caused by 21-hydroxylase deficiency. Although others have proposed the detection of several corticosteroids by LC-MS/MS (15)(16)(17)(18), large blood or urea sample volumes were needed, and published results of clinical LC-MS/MS analysis of steroids in whole blood are lacking.

Glacial acetic acid, 17OHP, 6{alpha}-methylprednisolone (6MP), GirP, and related compounds were purchased from Sigma. HPLC-grade methanol and acetonitrile were obtained from LAB-SCAN Analytical Science (Labscan Ltd.). Blank human whole-blood samples were obtained from China Medical College Hospital (Taichung, Taiwan).

Standardized filter-paper forms (Standardized S&S 903 filter paper; Schleicher & Schuell) impregnated with whole capillary blood from CAH patients or 2- to 5-day-old infants were collected from the Department of Genetics, China Medical College Hospital (Taichung, Taiwan). Patients with confirmed CAH were between 1 and 14 years of age (three girls and one boy). All patients or their parents gave informed consent. The National Taiwan University Hospital (Taipei, Taiwan) kindly provided five dried filter-paper blood samples from CAH infants.

Samples were prepared from blood spots by simple solvent extraction. Four 3.175-mm (1/8-inch) circles from each blood spot (equivalent to 11.5 µL of whole blood) were excised from a 12.7-mm (1/2-inch) diameter dried-blood spot and placed in a flat-bottomed 96-well block automatically (individual 250-µL wells; Corning Incorporated) by a DELFIA DBS puncher (Wallac). A stock solution of extraction solvent (methanol) containing a known concentration of internal standard (50 µg/L 6MP) was prepared and added to each well (200 µL). The wells were capped and shaken on a Vibromix 203E flatbed shaker (Tehtnica Co.) for 50 min. Subsequently, the extracts were transferred, using a multichannel pipette, into a clean V-bottomed 96-well microplate (individual 220-µL wells; Corning). Each 96-well microplate was placed in an evaporator [Techne (Cambridge) Ltd], and the solutions were evaporated to dryness under a gentle stream of dry nitrogen. The residue in each well was derivatized with 160 µL of GirP solution (10 g/L in ethanol, 1 mL/L trichloroacetic acid as a catalyst), incubated at 65 °C for 50 min, and evaporated to dryness under a gentle stream of dry nitrogen. The GirP-derivatized 17OHP (GirP-17OHP) and 6MP (GirP-6MP) were reconstituted in 30 µL of 500 mL/L acetonitrile. The plate was covered with aluminum foil and placed on an autosampler tray for microbore HPLC-ESI-MS/MS analysis.

The HPLC system consisted of two Perkin-Elmer Series 200 micropumps (PE-Sciex). HPLC analysis was performed in a 5-µm C4 microbore (Vydac) column [50 x 1.0 mm (i.d.)] operated at ambient temperature. A guard column (C4 cartridge; Vydac) was used to prolong the life of the HPLC column. The mobile phase was water–acetonitrile (50:50 by volume), and the flow rate was 50 µL/min. The autosampler was a Perkin-Elmer Series 200 autosampler fitted with a 10-µL loop (PE-Sciex) and equipped with a 96-well sample plate stack.

We used an API 2000 bench-top triple quadrupole mass spectrometer (PE-Sciex) operated in ion evaporation mode with a TurboIonSpray ionization probe source (operated at 5 kV). The TurboIonSpray ionization probe was operated with the turbo gas on (5 L/min; sensor temperature, 300 °C). The collision energy (Q0-RO2) was varied from -30 to -40 V. The orifice (OR) and ring (RNG) voltages were set at 50 and 360 V, respectively. Sample control (Ver. 1.4), TurboQuant (Ver. 1.0), and Microsoft Excel (Ver. 6.0) were used for data processing and statistical analysis. Background subtraction and a three-point smoothing algorithm were applied to all ion chromatograms and viewed using MultiView (Ver. 1.4) software.

Immunoassay of 17OHP was carried out with the IMMULITE analyzer (DPC), and the procedures for preparation, setup, dilutions, adjustment, assay, and quality control procedures as given in the IMMULITE operator’s manual (19).

For GirP-17OHP and GirP-6MP, the [M]2+ (m/z 299 and 321) ion was the most abundant in full-scan mode. The derivatized steroids had 10-fold higher ESI-MS/MS sensitivity than did the underivatized steroids because the precharged property of GirP-derivatized steroids (data not shown). We used multiple reaction monitoring, with Q1 transmitting the [M]2+ parent ions and Q3 monitoring the daughter ion signals. Under optimal isocratic conditions (acetonitrile–water, 50:50 by volume), GirP-17OHP and GirP-6MP were observed by LC-MS/MS. The monitored reactions and multiple reaction monitoring chromatograms for 17OHP and 6MP in dried-blood specimens are shown in Fig. 1 .



View larger version (18K):
[in this window]
[in a new window]
 
Figure 1. Mass chromatograms of GirP-17OHP and internal standard GirP-6MP (10 ng in 30 µL of mobile phase) obtained from dried-blood specimen (containing 500 µg/L 17OHP).

Instrument in multiple reaction monitoring mode. Mobile phase: H2O–acetonitrile (50:50 by volume).

Because no buffers were used in the mobile phases, ~300 samples were analyzed without instrument cleaning. Each run required 3 min, and intersample time delay was not needed. The retention times of the analytes were highly reproducible (CV = 2.6%; mean = 1.50 min; n = 50 for 17OHP), indicating that chromatographic stability was not sacrificed by either the lack of buffer or the short column equilibration. We replaced the guard column after analysis of 200–300 samples. The column pressure for the microbore HPLC column remained normal in the present study (400~500 samples). The R2 of the calibration curve (30–500 µg/L) was 0.991–0.997 (median, 0.995). The limit of detection was 10 µg/L (~12 µL of whole blood) based on a signal-to-noise ratio of 3. Analytical recovery of added 17OHP was 76–82% (30–250 µg/L added). CVs for dried-blood spots of uniform size under these conditions were <7%, suggesting that methanol is a suitable eluant for removing 17OHP from blood spots. The interassay CV for 17OHP was 4.3–10%, and the intraassay CV was <12%.

The results of the quantification of 17OHP from dried-blood spots in the control and CAH groups by LC-MS/MS and RIA are shown in Table 1 . 17OHP in all dried-blood samples could be quantified by immunoassay. In the control groups, measured 17OHP was 3–12 µg/L in the RIA (median, 6 µg/L). In the LC-MS/MS analyses, 17OHP was <20 µg/L in the control groups, although the internal standard (6MP) was readily detected in all cases.


View this table:
[in this window]
[in a new window]
 
Table 1. 17OHP concentration in dried-blood spots from healthy controls and CAH patients by LC-MS/MS and RIA.

We used LC-MS/MS to monitor the treatment of four CAH patients (Table 1Up , patients 1–4). Repeated blood sampling on filter paper can assist in improving the monitoring of CAH treatment. After treatment, 17OHP decreased in all patients. 17OHP was increased in dried filter-paper blood samples from five CAH infants (Table 1Up , patients 5–9). The detection of 17OHP by the present method was inferior to that obtained by the immunoassay, but was adequate for determining 17OHP in CAH patients.

The high-throughput CAH screening method described in this report, although it includes a derivatization step, does not require long and complicated preparation of samples. Measurement of 17OHP in dried blood on filter paper by LC-MS/MS is simple to carry out. The method provides analytical specificity and eliminates handling of radioactive materials. The LC-MS/MS assay appears useful not only for diagnosis and monitoring of treatment of CAH in all age groups, but also for screening for CAH in infants.


Acknowledgments

The study was funded by a grant from China Medical College Hospital (DMR-91-101). We thank National Taiwan University Hospital for providing five dried filter-paper blood samples from CAH infants.


References

  1. Pang S, Wallace MA, Hofman L, Thuline HC, Dorche C, Lyon ICT, et al. Worldwide experience in newborn screening for classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Pediatrics 1998;81:866-874.[Abstract/Free Full Text]
  2. Mitchell ML, Hermos RJ. Cortisol in dried blood screening specimens from newborns with raised 17-hydroxyprogesterone and congenital adrenal hyperplasia. Clin Endocrinol 1998;48:757-760.[Medline] [Order article via Infotrieve]
  3. Boudi A, Giton F, Galons H, Eulry B, Villette JM, Soliman H, et al. Development of a plasma 17{alpha}-hydroxyprogesterone time resolved-fluorescence immunoassay involving a new biotinylated tracer. Steroids 2000;65:103-108.[Web of Science][Medline] [Order article via Infotrieve]
  4. Katayama M, Nakane R, Matsuda Y, Kaneko S, Hara I, Sato H. Determination of progesterone and 17-hydroxyprogesterone by high performance liquid chromatography after pre-column derivatization with 4,4-difluoro-5,7-dimethyl-4-bora-3a,4a-diaza-s-indacene-3-propionohydrazide. Analyst 1998;123:2339-2342.[Medline] [Order article via Infotrieve]
  5. Castracane VD, Gimpel T. Comparison of three methods for 17{alpha}-hydroxyprogesterone. J Clin Lab Anal 1997;11:179-185.[Web of Science][Medline] [Order article via Infotrieve]
  6. Nahoul K. Plasma 17-hydroxyprogesterone determination with two commercial immunoassays. J Steroid Biochem Mol Biol 1994;50:197-203.[Web of Science][Medline] [Order article via Infotrieve]
  7. Sainio EL, Lehtola T, Roininen P. RIA of total and free corticosterone in rat plasma: measurement of the effect of different doses of corticosterone. Steroids 1988;51:609-622.[Medline] [Order article via Infotrieve]
  8. Erhardt E, Solyom J, Homoki J, Juricskay S, Soltesz G. Correlation of blood-spot 17-hydroxyprogesterone daily profiles and urinary steroid profiles in congenital adrenal hyperplasia. J Pediatr Endocrinol Metab 2000;13:205-210.[Web of Science][Medline] [Order article via Infotrieve]
  9. Saisho S, Shimozawa K, Yata J. Changes of several adrenal {Delta}-4-steroids measured by HPLC-UV spectrometry in neonatal patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Horm Res 1990;33:27-34.[Web of Science][Medline] [Order article via Infotrieve]
  10. Hariharan M, Naga S, VanNoord T, Kindt EK. Simultaneous assay of corticosterone and cortisol in plasma by reversed-phase liquid chromatography. Clin Chem 1992;38:346-352.[Abstract/Free Full Text]
  11. Wang T, Shakleton CHL, Covey TR, Ellis G. Identification of the steroids in neonatal plasma that interfere with 17{alpha}-hydroxyprogesterone RIAs. Clin Chem 1992;38:1830-1837.[Abstract/Free Full Text]
  12. Honour JW, Rumsby G. Problems in diagnosis and management of congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Steroid Biochem Mol Biol 1993;45:69-74.[Web of Science][Medline] [Order article via Infotrieve]
  13. Lo MS, Ng ML, Wu LL, Azmy BS, Khalid BA. Usefulness and limitations of an in-house direct RIA for 17-hydroxyprogesterone in serum. Malays J Pathol 1996;18:43-52.[Medline] [Order article via Infotrieve]
  14. Gorog S, Gazdag M, Kemenes-Bakos P. Analysis of steroids. Part 50. Derivatization of ketosteroids for their separation and determination by capillary electrophoresis. J Pharm Biomed Anal 1996;14:1115-1124.[Web of Science][Medline] [Order article via Infotrieve]
  15. Volmer DA, Hui JPM. Rapid determination of corticosteroids in urine by combined solid phase microextraction/liquid chromatography/mass spectrometry. Rapid Commun Mass Spectrom 1997;11:1926-1934.[Web of Science][Medline] [Order article via Infotrieve]
  16. Dodds HM, Taylor PJ, Cannell GR, Pond SM. A high-performance liquid chromatography-electrospray-tandem mass spectrometry analysis of cortisol and metabolites in placental perfusate. Anal Biochem 1997;247:342-347.[Web of Science][Medline] [Order article via Infotrieve]
  17. Fiori M, Pierdominici E, Longo F, Brambilla G. Identification of main corticosteroids as illegal feed additives in milk replacers by liquid chromatography-atmospheric pressure chemical ionisation mass spectrometry. J Chromatogr A 1998;807:219-227.[Web of Science][Medline] [Order article via Infotrieve]
  18. Antignac JP, Bizec BL, Monteau F, Poulain F, Andre F. Collision-induced dissociation of corticosteroids in electrospray tandem mass spectrometry and development of a screening method by high performance liquid chromatography/tandem mass spectrometry. Rapid Commun Mass Spectrom 2000;14:33-39.[Web of Science][Medline] [Order article via Infotrieve]
  19. Burtis CA Ashwood ER eds. Tietz textbook of clinical chemistry, 3rd ed 1999:1557-1563 WB Saunders Philadelphia. .



The following articles in journals at HighWire Press have cited this article:


Home page
J. Clin. Endocrinol. Metab.Home page
C. Z. Minutti, J. M. Lacey, M. J. Magera, S. H. Hahn, M. McCann, A. Schulze, D. Cheillan, C. Dorche, D. H. Chace, J. F. Lymp, et al.
Steroid Profiling by Tandem Mass Spectrometry Improves the Positive Predictive Value of Newborn Screening for Congenital Adrenal Hyperplasia
J. Clin. Endocrinol. Metab., August 1, 2004; 89(8): 3687 - 3693.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Extract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (9)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lai, C.-C.
Right arrow Articles by Lee, C.-C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lai, C.-C.
Right arrow Articles by Lee, C.-C.
Related Collections
Right arrow Molecular Diagnostics and Genetics
Right arrow Endocrinology and Metabolism


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS